These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2418384)

  • 41. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R; Stern Y; Sano M; Williams JB; Cote LJ
    Mov Disord; 1988; 3(3):237-44. PubMed ID: 2461509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid monoamine and monoamine metabolite levels and the dexamethasone suppression test in depression. Relationship to life events.
    Roy A; Pickar D; Linnoila M; Doran AR; Paul SM
    Arch Gen Psychiatry; 1986 Apr; 43(4):356-60. PubMed ID: 2420302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms.
    Meltzer HY; Perline R; Tricou BJ; Lowy M; Robertson A
    Arch Gen Psychiatry; 1984 Apr; 41(4):379-87. PubMed ID: 6608336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenocortical function and suicidal behavior in depressive disorders.
    Brown RP; Mason B; Stoll P; Brizer D; Kocsis J; Stokes PE; Mann JJ
    Psychiatry Res; 1986 Apr; 17(4):317-23. PubMed ID: 3714913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients.
    Edman G; Asberg M; Levander S; Schalling D
    Arch Gen Psychiatry; 1986 Jun; 43(6):586-92. PubMed ID: 2423049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
    Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dexamethasone suppression test in suicidal patients with unipolar depression.
    Targum SD; Rosen L; Capodanno AE
    Am J Psychiatry; 1983 Jul; 140(7):877-9. PubMed ID: 6859303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid somatostatin and psychiatric illness.
    Rubinow DR
    Biol Psychiatry; 1986 Apr; 21(4):341-65. PubMed ID: 2869790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Life at risk: markers of suicidality in depression.
    Agren H
    Psychiatr Dev; 1983; 1(1):87-103. PubMed ID: 6201842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulatory effects of L-5-hydroxytryptophan on postdexamethasone beta-endorphin levels in major depression.
    Maes M; Van Gastel A; Ranjan R; Blockx P; Cosyns P; Meltzer HY; Desnyder R
    Neuropsychopharmacology; 1996 Oct; 15(4):340-8. PubMed ID: 8887988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (Auto)aggression and serotonin. A review of human data.
    De Cuyper H
    Acta Psychiatr Belg; 1987; 87(3):325-31. PubMed ID: 2445174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP; Berger PA; Brodie KH; Sack R; Barchas JD
    Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients.
    Mann JJ; McBride PA; Brown RP; Linnoila M; Leon AC; DeMeo M; Mieczkowski T; Myers JE; Stanley M
    Arch Gen Psychiatry; 1992 Jun; 49(6):442-6. PubMed ID: 1376106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CSF 5-HIAA and the rorschach test in patients who have attempted suicide.
    Lundbäck E; Forslund K; Rylander G; Jokinen J; Nordström P; Nordström AL; Asberg M
    Arch Suicide Res; 2006; 10(4):339-45. PubMed ID: 16920684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies of CSF 5-HIAA in depression and suicidal behaviour.
    Asberg M; Träskman L
    Adv Exp Med Biol; 1981; 133():739-52. PubMed ID: 6172023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.
    Malone KM; Waternaux C; Haas GL; Cooper TB; Li S; Mann JJ
    Am J Psychiatry; 2003 Apr; 160(4):773-9. PubMed ID: 12668368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan.
    Pranzatelli MR; Tate E; Huang Y; Haas RH; Bodensteiner J; Ashwal S; Franz D
    Epilepsia; 1995 Aug; 36(8):783-91. PubMed ID: 7543407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia.
    Cooper SJ; Kelly CB; King DJ
    Lancet; 1992 Oct; 340(8825):940-1. PubMed ID: 1383659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.